Synairgen (GB:SNG) has released an update.
Synairgen plc, a UK-based respiratory company, has issued 1,285,722 new ordinary shares following the exercise of options by an ex-employee. These shares will begin trading on AIM on November 5, 2024, increasing the company’s total voting rights to 202,660,697. This move could impact shareholder interests and transparency requirements under FCA guidelines.
For further insights into GB:SNG stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
